Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2018

01-06-2018 | Retinal Disorders

The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels

Authors: Emine Çiloğlu, Fikret Unal, Nese Cetin Dogan

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 6/2018

Login to get access

Abstract

Purpose

The purpose of this study were to compare the levels of serum cortisol, aldosterone, testosterone, dehydroepiandrosterone (DHEA), and renin hormone between patients with central serous chorioretinopathy (CSC) and a control group, and to investigate whether there was a difference regarding serum hormone levels in patients with acute/chronic CSC.

Methods

This prospective study included 30 CSC eyes, 30 fellow eyes, and 32 normal eyes of 32 healthy volunteers who were age and sex matched. The patients were classified as acute or chronic depending on the clinical, fluorescein angiography (FFA), and optical coherence tomography (OCT) findings. Serum cortisol, aldosterone, renin, total testosterone, and DHEA levels were measured. The levels of hormones were compared with the values of the control group. Choroidal thickness and central macular thickness were measured with spectral domain OCT.

Results

Fifteen patients had acute CSC, and 15 patients had chronic CSC. Serum testosterone levels were 357 ± 10.4 ng/ml in the CSC group, and 255.94 ± 7.43 ng/ml in the control group. The difference between them was statistically significant (p < 0.001). The difference between the levels of cortisol, renin, aldosterone, and DHEA was not statistically significant. Serum hormone levels were within the normal range for all patients and were not statistically different between the acute and chronic CSC groups.

Conclusion

According to our results, CSC is related to elevated total testosterone levels. Testosterone may play a role in predisposing males to CSC.
Literature
1.
go back to reference Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 115:169–173CrossRefPubMed Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 115:169–173CrossRefPubMed
2.
go back to reference Wang M, Munch IC, Hasler PW, Prünte C, Larsen M (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145CrossRefPubMed Wang M, Munch IC, Hasler PW, Prünte C, Larsen M (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145CrossRefPubMed
3.
go back to reference Hussain D, Gass JD (1998) Idiopathic central serous chorioretinopathy. Indian J Ophthalmol 46(3):131–137PubMed Hussain D, Gass JD (1998) Idiopathic central serous chorioretinopathy. Indian J Ophthalmol 46(3):131–137PubMed
4.
go back to reference Gass JDM (1997) Stereoscopic atlas of macular diseases, 4th edn. Mosby, St. Louis, MO, pp 760–763 Gass JDM (1997) Stereoscopic atlas of macular diseases, 4th edn. Mosby, St. Louis, MO, pp 760–763
5.
go back to reference Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112(8):1057–1062CrossRefPubMed Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112(8):1057–1062CrossRefPubMed
6.
go back to reference Prünte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121(1):26–34CrossRefPubMed Prünte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121(1):26–34CrossRefPubMed
7.
go back to reference Kim YT, Kang SW, Bai KH (2011) Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy. Eye (Lond) 25(12):1635–1640CrossRef Kim YT, Kang SW, Bai KH (2011) Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy. Eye (Lond) 25(12):1635–1640CrossRef
8.
go back to reference Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S (2004) Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111:244–249CrossRefPubMed Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S (2004) Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111:244–249CrossRefPubMed
9.
go back to reference Liew G, Quin G, Gillies M, Fraser-Bell S (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 41:201–214CrossRefPubMed Liew G, Quin G, Gillies M, Fraser-Bell S (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 41:201–214CrossRefPubMed
10.
go back to reference Gelber GS, Schatz H (1987) Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 144(1):46–50CrossRefPubMed Gelber GS, Schatz H (1987) Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 144(1):46–50CrossRefPubMed
11.
12.
go back to reference Zakir SM, Shukla M, Simi SU, Ahmad J, Sajid M (2009) Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy. Indian J Ophthalmol 57(6):419–422CrossRefPubMedPubMedCentral Zakir SM, Shukla M, Simi SU, Ahmad J, Sajid M (2009) Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy. Indian J Ophthalmol 57(6):419–422CrossRefPubMedPubMedCentral
13.
go back to reference Garg SP, Dada T, Talwar D, Bidwas NR (1997) Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 81(11):962–964CrossRefPubMedPubMedCentral Garg SP, Dada T, Talwar D, Bidwas NR (1997) Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 81(11):962–964CrossRefPubMedPubMedCentral
14.
go back to reference Thoelen AM, Bernasconi PP, Schmid C, Messmer EP (2000) Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina 20:98–99CrossRefPubMed Thoelen AM, Bernasconi PP, Schmid C, Messmer EP (2000) Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina 20:98–99CrossRefPubMed
15.
go back to reference Pastor-Idoate S, Pena D, Herreras JM (2011) Adrenocortical adenoma and central serous chorioretinopathy: a rare association? Case Rep Ophthalmol 2:327–332CrossRefPubMedPubMedCentral Pastor-Idoate S, Pena D, Herreras JM (2011) Adrenocortical adenoma and central serous chorioretinopathy: a rare association? Case Rep Ophthalmol 2:327–332CrossRefPubMedPubMedCentral
16.
go back to reference Chalisgaonkar C, Chouhan S, Lakhtakia S et al (2010) Central serous chorioretinopathy and endogenous cortisol: is there an association? Indian J Ophthalmol 58:449–450CrossRefPubMedPubMedCentral Chalisgaonkar C, Chouhan S, Lakhtakia S et al (2010) Central serous chorioretinopathy and endogenous cortisol: is there an association? Indian J Ophthalmol 58:449–450CrossRefPubMedPubMedCentral
17.
go back to reference Tufan HA, Gencer B, Comez AT (2013) Serum cortisol and testosterone levels in chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 251:677–680CrossRefPubMed Tufan HA, Gencer B, Comez AT (2013) Serum cortisol and testosterone levels in chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 251:677–680CrossRefPubMed
18.
go back to reference Zumoff B, Rosenfeld RS, Friedman M, Byers SO, Rosenman RH, Hellman L (1984) Elevated daytime urinary excretion of testesterone glucuronide in men with type A behavior pattern. Psychocom Med 46:223–225CrossRef Zumoff B, Rosenfeld RS, Friedman M, Byers SO, Rosenman RH, Hellman L (1984) Elevated daytime urinary excretion of testesterone glucuronide in men with type A behavior pattern. Psychocom Med 46:223–225CrossRef
19.
go back to reference Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, Toda I, Sullivan BD, Sullivan DA (2000) Identification of androgen receptor protein and 5 alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 84:76–84CrossRefPubMedPubMedCentral Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, Toda I, Sullivan BD, Sullivan DA (2000) Identification of androgen receptor protein and 5 alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 84:76–84CrossRefPubMedPubMedCentral
20.
go back to reference Ahad MA, Chua CN, Evans NM (2006) Central serous chorioretinopathy associated with testosterone therapy. Eye (Lond) 20:503–505CrossRef Ahad MA, Chua CN, Evans NM (2006) Central serous chorioretinopathy associated with testosterone therapy. Eye (Lond) 20:503–505CrossRef
21.
go back to reference Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29(10):1469–1473CrossRefPubMed Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29(10):1469–1473CrossRefPubMed
22.
go back to reference Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T (2011) Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 31(8):1603–1608CrossRefPubMed Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T (2011) Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 31(8):1603–1608CrossRefPubMed
23.
go back to reference Lıu T, Dong Y, Zeng DF, Xıe L, Ye J, He XG (2014) Acase of adult-onset Still’s disease presenting with multifocal central serous chorioretinopathy. Eur Rev Med Pharmacol Sci 18:421–425PubMed Lıu T, Dong Y, Zeng DF, Xıe L, Ye J, He XG (2014) Acase of adult-onset Still’s disease presenting with multifocal central serous chorioretinopathy. Eur Rev Med Pharmacol Sci 18:421–425PubMed
24.
go back to reference Yang LH, Tian B, Shi XH, Ding N, Zhou D, Wei WB (2012) Changes in choroidal thickness in central serous chorioretinopathy. Zhonghua Yan Ke Za Zhi 48:872–877 Yang LH, Tian B, Shi XH, Ding N, Zhou D, Wei WB (2012) Changes in choroidal thickness in central serous chorioretinopathy. Zhonghua Yan Ke Za Zhi 48:872–877
25.
go back to reference Watanabe S, Ohtsuki K (1979) Experimental serous chorioretinopathy. Ada Soc Ophthalmol Jpn 83(7):808–817 Watanabe S, Ohtsuki K (1979) Experimental serous chorioretinopathy. Ada Soc Ophthalmol Jpn 83(7):808–817
26.
go back to reference Yoshioka H (1991) The etiology of central serous chorioretinopathy. Ada Soc Ophthalmol Jpn 95(12):1181–1195 Yoshioka H (1991) The etiology of central serous chorioretinopathy. Ada Soc Ophthalmol Jpn 95(12):1181–1195
27.
go back to reference Zhao M, Célérier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672–2679CrossRefPubMedPubMedCentral Zhao M, Célérier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672–2679CrossRefPubMedPubMedCentral
28.
go back to reference Bonvalet JP (1998) Regulation of sodium transport by steroid hormones. Kidney Int Suppl 65:S49–S56PubMed Bonvalet JP (1998) Regulation of sodium transport by steroid hormones. Kidney Int Suppl 65:S49–S56PubMed
29.
go back to reference Bouzas EA, Karadımas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431–448CrossRefPubMed Bouzas EA, Karadımas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431–448CrossRefPubMed
30.
go back to reference Gong Q, Sun XH, Yuan ST, Lıu QH (2017) The releation of the serum aldosterone level and central serous chorioretinopathy-a pilot study. Eur Rev Med Pharmacol Sci 21:446–453PubMed Gong Q, Sun XH, Yuan ST, Lıu QH (2017) The releation of the serum aldosterone level and central serous chorioretinopathy-a pilot study. Eur Rev Med Pharmacol Sci 21:446–453PubMed
31.
go back to reference Homovici R, Rumelt S, Melby J (2003) Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110:698–703CrossRef Homovici R, Rumelt S, Melby J (2003) Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110:698–703CrossRef
32.
33.
go back to reference Nudleman E, Witmer MT, Kiss S et al (2014) Central serous chorioretinopathy in patients receiving exogenous testosterone theraphy. Retina 34:2128–2132CrossRefPubMed Nudleman E, Witmer MT, Kiss S et al (2014) Central serous chorioretinopathy in patients receiving exogenous testosterone theraphy. Retina 34:2128–2132CrossRefPubMed
34.
go back to reference Conway MD, Noble JA, Peyman GA (2016) Central serous chorioretinopathy in postmenopausal women receiving exogenous testosterone. Retin Cases Brief Rep 0:1–5 Conway MD, Noble JA, Peyman GA (2016) Central serous chorioretinopathy in postmenopausal women receiving exogenous testosterone. Retin Cases Brief Rep 0:1–5
35.
go back to reference Natung T, Keditsu A (2015) Comparison of serum cortisol and testosterone levels in acute and chronic central serous chorioretinopathy. Korean J Ophthalmol 29(6):382–388CrossRefPubMedPubMedCentral Natung T, Keditsu A (2015) Comparison of serum cortisol and testosterone levels in acute and chronic central serous chorioretinopathy. Korean J Ophthalmol 29(6):382–388CrossRefPubMedPubMedCentral
36.
go back to reference Islam QU, Hanif MK, Tareen S (2016) Frequency of systemic risk factors in central serous chorioretinopathy. J Coll Physicians Surg Pak 26(8):692–695PubMed Islam QU, Hanif MK, Tareen S (2016) Frequency of systemic risk factors in central serous chorioretinopathy. J Coll Physicians Surg Pak 26(8):692–695PubMed
37.
go back to reference Turkcu FM, Yuksel H, Yuksel H, Sahin A, Cınar Y, Cingu AK, Sahın M, Caca İ (2014) Serum dehydroepiandrosterone sulphate, total antioxidant capacity and total oxidant status in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 252(1):17–21CrossRefPubMed Turkcu FM, Yuksel H, Yuksel H, Sahin A, Cınar Y, Cingu AK, Sahın M, Caca İ (2014) Serum dehydroepiandrosterone sulphate, total antioxidant capacity and total oxidant status in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 252(1):17–21CrossRefPubMed
Metadata
Title
The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels
Authors
Emine Çiloğlu
Fikret Unal
Nese Cetin Dogan
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 6/2018
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-3985-x

Other articles of this Issue 6/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2018 Go to the issue